We demonstrated that PRDM6 expression occurs almost exclusively in tumor cells of clinical HNSCC tissues and that PRDM6 promotes proliferation and growth of HNSCC tumor cells in vitro while suppressing expression of anti-tumor ISGs (ISG15, IFITM1) by both loss- and gain-of-function approaches. Here, PRDM6 is linked to neoplasm.